ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.

Biotechnology

ImmunityBio

Rich Adcock

Philip Loscalzo

Regan Lauer

Helen Luu

Patrick Soon-Shiong

Barry Simon

Jason Liljestrom

Sarah Singleton

Leonard S. Sender

David Sachs

Executive Team

Research and Development

Leadership Team

Accounting and Finance Team

Clinical Operations Team

Quality Assurance and Compliance Team

Teams at ImmunityBio